RIP: After burning through $463M, StemCells’ corpse is bought out for the public shell
Back at the end of May, Newark, CA-based StemCells $STEM joined the walking dead of biotech. Running out of cash, its Phase II spinal cord …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
